ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
58,699.14
1.40%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Xtract Resources Plc (XTR) Quote

Xtract Resources Plc

Xtract Resources Plc (XTR)

Global X S&P 500 Tail Risk ETF
iShares Diversified Monthly Income ETF
0.90
0.00
(0.00%)
Closed July 13 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.90
Bid
0.80
Ask
1.00
Volume
391,724
0.90 Day's Range 0.90
0.775 52 Week Range 1.90
Market Cap
7.707M
Previous Close
0.90
Open
0.90
Last Trade
1750
@
0.83
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
670,744
Shares Outstanding
856,375,115
Dividend Yield
-
PE Ratio
-4.29
Earnings Per Share (EPS)
-0
Revenue
2.81M
Net Profit
-1.83M

About Xtract Resources Plc

Sector
Gold Ores
Industry
Offices-holdng Companies,nec
Website
www.xtractresources.com
Headquarters
London, Gbr
Founded
2013
Xtract Resources Plc is listed in the Gold Ores sector of the London Stock Exchange with ticker XTR. The last closing price for Xtract Resources was 0.90p. Over the last year, Xtract Resources shares have traded in a share price range of 0.775p to 1.90p.

Xtract Resources currently has 856,375,115 shares outstanding. The market capitalization of Xtract Resources is £7.71 million. Xtract Resources has a price to earnings ratio (PE ratio) of -4.29.

XTR Latest News

More News

Xtract Resources plc Notice of AGM

Xtract Resources plc 08 July 2024       8 July 2024 Xtract Resources Plc ("Xtract" or the "Company") Notice of Annual General Meeting (the "Notice")   Xtract Resources Plc ("Xtract" or the...

July 08 2024
RNS Regulatory News

EARNINGS AND TRADING: Fenikso in profit; Tate & Lyle completes sale

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

June 27 2024
Alliance News

Xtract Resources plc Final Results

Xtract Resources plc 27 June 2024         For immediate release  27 June 2024   Xtract Resources Plc ("Xtract" or the "Company") Audited results for the 12 months ended 31 December 2023   The...

June 27 2024
RNS Regulatory News

EARNINGS AND TRADING: RiverFort Global net asset value decreases

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...

June 18 2024
Alliance News

Xtract Resources plc Bushranger second stage pre-concentration study

Xtract Resources plc 18 June 2024   18 June 2024 Xtract Resources Plc ("Xtract" or the "Company") Second Stage Pre-Concentration study for the Bushranger Copper-Gold Project The Board of...

June 18 2024
RNS Regulatory News

Xtract Resources plc Additional Zambian Exploration Licences - Replace

Xtract Resources plc 31 May 2024         This release replaces RNS 4538Q released on 30 May 2024 at 10:00. The following changes have been made in the 2nd, 3rd and 4th paragraphs under the...

May 31 2024
RNS Regulatory News

Xtract Resources plc Additional Zambian exploration licences

Xtract Resources plc 30 May 2024     30 May 2024 Xtract Resources Plc ("Xtract" or the "Company") Additional Zambian Joint Venture Exploration Licences   The Board of Xtract Resources Plc...

May 30 2024
RNS Regulatory News

Xtract Resources enters joint venture for Zambian copper project

Xtract Resources PLC said on Wednesday that it has entered into a joint venture with Oval Mining Ltd who are acting i ...

April 03 2024
Alliance News

Xtract Resources plc Zambian Exploration Licence Joint Venture

Xtract Resources plc 03 April 2024     For immediate release 3 April 2024 Xtract Resources Plc ("Xtract" or the "Company")   Zambian Exploration Licence Joint Venture   The Board of Xtract...

April 03 2024
RNS Regulatory News

Xtract Resources plc Completion of Disposal of Manica Gold Project

Xtract Resources plc 23 February 2024     23 February 2024 Xtract Resources Plc ("Xtract" or the "Company") Completion of Disposal of Manica Gold Project   The Board of Xtract is pleased to...

February 23 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.90.90.858201600.89182797DE
4-0.125-12.19512195121.0251.0250.7758954960.87573286DE
12-0.125-12.19512195121.0251.10.7756707440.94455907DE
26-0.325-26.53061224491.2251.4750.77512135681.00826488DE
52-0.55-37.93103448281.451.90.77511017481.13453745DE
156-2.75-75.34246575343.657.350.77520929713.75824361DE
260-0.325-26.53061224491.2259.150.533186783.86496268DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Discussion

View Full Feed
LVerstee LVerstee 37 seconds ago
I regret to inform you that you are mistaken. Your employee, RD, was actively involved in advising board members on this and other boards to purchase additional tokens or shares. RD even recommended that individuals use the profits from sold shares to invest in this endeavor.
ITUP
Hopeforthefuture3 Hopeforthefuture3 1 minute ago
Where do you get the 50% cure figure for gbm? The trial has 13% long term (5 year) survivors. The trial including poly-iclc had 4 gbm cases and the one with longest survival did not include the adjuvant
NWBO
Dj56 Dj56 1 minute ago
25:34

BREAKTHROUGHS in medicine sooner than later due to A.I., + major medical accomplishments in medicine of what AI has recently done.

https://youtu.be/0_M_syPuFos?si=xw4_LYLysSz8ExAt

RSPI
ap17 ap17 2 minutes ago
I went fishing once in seas like that 40' swells, threw up more times than I can count just on the way out. 30 miles west of SF.
XRPUSD
cadillacdave cadillacdave 3 minutes ago
Some news will come out, hopefully sooner than later. They are working on something behind the scenes. Whether or not it comes to fruition, we will have to wait and see.
WDDD
RealDutch RealDutch 3 minutes ago
Question and ridicule? Is posing a legitimate question classified as such?

It's the way you ask them. And the number of questions you ask.

It is peculiar that you are opposing shareholders, requesting them to contribute additional funds, yet expecting them to remain sil
ITUP
al44 al44 4 minutes ago
Ever wondered why?-

https://media.gettr.com/group8/getter/2024/07/13/11/ec24fa7d-81cf-9057-5784-7ef26c317307/2b91e610272c2d0e0b64462e3b0408ec_768x0.jpg
flipper44 flipper44 4 minutes ago
“In the case of a novel biologic undergoing a 150-day accelerated review for marketing authorization application (MAA) in the UK, inspections or a Request for Information (RFI) may not always be necessary if the therapy has been used for ten years as a compassionate treatment for a specific cancer i
NWBO
nathanial nathanial 5 minutes ago
Excellent point. Just because the Dr posted July 9 it was accepted, the effective date of submission was June 28. That is the date the FDA received it.....point blank.
RDGL
ap17 ap17 5 minutes ago
YEP, at least with Mt. Gox you're looking at 1000's of forced BTC long's that bought in for 100.00's and some will be smart enough to hold.
BTCUSD
al44 al44 5 minutes ago
In case you forgot-

https://media.gettr.com/group8/getter/2024/07/12/20/1556c625-87f3-ef39-eee7-9866d3bb073b/160789f04734afc311cdb99ede199bf8_768x0.jpg
JOHNNIEBG JOHNNIEBG 5 minutes ago
It is people like him that make the large majority of people in the world sick to think what a second term of Donnie would do to the Already Great America !!!!!!!!!!!!!!

It is scary to know that people like him actually exist and actually believe what they are saying all because Donni
palaypu0406 palaypu0406 6 minutes ago
Being a CPA and CA, myself, with 40 years of management experience, without contingency planning we never move an inch LVerstee...
For everything, we make plan A, Plan B, Plan c and Plan D...
ITUP
mike00h mike00h 7 minutes ago
I’ve heard that a lot of money is skimmed out of the OTC by market makers and more taken through spoofing and manipulation. Since they have no scruples do they try to influence regulatory authorities? Bribes? Blackmail? Influence? Big Pharma’s been doing that to US congress for decades, or so I’ve h
NWBO
Lykiri Lykiri 7 minutes ago
I think Owain James is the patient.

I'm so sorry to hear about the passing of Owain James.
https://x.com/FundsForOwain/status/1806963918201377111
NWBO
palaypu0406 palaypu0406 8 minutes ago
It is the other way round Lverstee...
We have been quite entrepreneurial ...
We never sought money from any outsider (not a single new investor) ...
Our time was our immeasurable investment more than what we took support from shareholders as cash...
In the millions of dol
ITUP
Seminole Red Seminole Red 8 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/450623386_122156120222136702_3891421874257498899_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=127cfc&_nc_ohc=v59L4AmuoO8Q7kNvgGsb92-&_nc_ht=scontent-mia3-2.xx&oh=00_AYA7hMC2vf3-nIgQ-fAo30hf-TxETlMmnapDy5Sgd-t5fQ&oe=6698C486
XenaLives XenaLives 8 minutes ago
It's been too long - see replied to post...

zebra2142

Re: None

Monday, January 30, 2023 11:07:43 AM

Post# 131857 of 196427
All you need to know about Kerrisdale Capital:

"The Department of Justice and the U.S. Securit
LWLG
Truthsocial Truthsocial 9 minutes ago
If chat GPT says it it has to be true lol ...what happened to thinking for yourself

Exactly always a wench in the circle.....look at the FDA guidelines and don't read into abc.

Of course we knew the answer

Remember June 28th submitted following week was
SMH
Sammy 967 Sammy 967 10 minutes ago
Question is how much is VAZKEPA is in China and most important question is how many people there can afford it.
AMRN
mattsinvestmentclub mattsinvestmentclub 10 minutes ago
Yes, waiting for updates after goldsteins "plaintiff" lawyers backed out for "unknown" reasons.
Plausible reasons include Goldstein lied about something.
could be they saw the evidence submitted by Omni/soloviev and realized Goldstein wasn't forth coming.
Could be something co
OMHE
Hopeforthefuture3 Hopeforthefuture3 12 minutes ago
Manibiotech, you are entirely correct. The 'paid pumpers' do not want to debate any facts or suggest what management could do better they just hurl insults. I believe in the science since I first read the 2011 paper by Prins and Liau but nwbo management imo needs to a better job of telling the story
NWBO
JMoneyHoops JMoneyHoops 12 minutes ago
Yep I definitely will be, nothing new since the May 14th court submission
BCAP

Your Recent History

LSE
XTR
Xtract Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved